retatrutide triple hormone receptor agonist obesity mechanism of action Dual and Gut Peptide Agonists on the Horizon for the Treatment Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Retatrutide Availability: Everything You Need

The preclinical data suggests the hypothesis that inhibitory GIPR + neurons act specifically on GLP-1R + neurons that drive nausea and food aversion or avoidance to dampen GLP-1R mediated nausea without reducing efficacy, potentially lifting the ceiling of GLP-1R agonist-induced reductions in body weight

Other medications may also have certain impacts when taken with Wegovy, so informing your healthcare provider about the medications you take is essential in ensuring the safety and effectiveness of Wegovy

If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html

If the FDA ultimately adopts the recommendations, implementation details will matter

Dietary Guidelines for Americans, 20202025, Executive Summary